Improved treatment satisfaction with once-weekly IcoSema vs daily basal-bolus therapy in adults with type 2 diabetes inadequately controlled on daily basal insulin (COMBINE 3)
Authors:
Paolo Fiorina1; Malik Benamar2; Sin Gon Kim3; Raluca Maltesen4; Siri Vinther2; Liming Chen5